Enlivex Therapeutics (ENLV) has released an update.
Enlivex Therapeutics Ltd., a company working on therapeutic candidates, has reportedly maintained a fair financial position as of December 31, 2023, according to audited financial statements. The independent audit confirmed the company’s effective internal control over financial reporting and acknowledged the company’s reliance on raising funds to support operations, with enough liquidity for the next 12 months.
For further insights into ENLV stock, check out TipRanks’ Stock Analysis page.
